Oxford BioMedica PLC
LSE:OXB
Oxford BioMedica PLC
Revenue
Oxford BioMedica PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Oxford BioMedica PLC
LSE:OXB
|
Revenue
£119m
|
CAGR 3-Years
22%
|
CAGR 5-Years
16%
|
CAGR 10-Years
36%
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Revenue
$6.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Revenue
$1.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Revenue
$41.6m
|
CAGR 3-Years
55%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Revenue
£249.4m
|
CAGR 3-Years
102%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Revenue
£673.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
See Also
What is Oxford BioMedica PLC's Revenue?
Revenue
119m
GBP
Based on the financial report for Jun 30, 2023, Oxford BioMedica PLC's Revenue amounts to 119m GBP.
What is Oxford BioMedica PLC's Revenue growth rate?
Revenue CAGR 10Y
36%
Over the last year, the Revenue growth was -5%. The average annual Revenue growth rates for Oxford BioMedica PLC have been 22% over the past three years , 16% over the past five years , and 36% over the past ten years .